Hongbo Pharmaceutical (301230.SZ): Shenyang Fubon plans to reduce its shareholding in the company by no more than 1%.

Zhongtong Finance and Economics APP News, Hongbo Medicine (301230.SZ) announced that Shenyang Fubon plans to reduce its holdings of the company's shares by no more than 1.37 million shares through centralized bidding or block trading within 3 months after the announcement date, which is 15 trading days after the announcement date. That is, the reduction ratio does not exceed 1.00% of the total share capital of the company after deducting the shares in the latest disclosed repurchase account.